Clinical Trial Update: Efcacy and Safety of Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With mFOLFOX in Hepatocellular Carcinoma With High-risk Recurrence Factors [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating the efficacy and safety of postoperative adjuvant hepatic arterial infusion chemotherapy using t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• mFOLFOX

Snippet

Sponsor: Northern Jiangsu People's Hospital | Conditions: Hepatocellular Carcinoma (HCC) | Phase 2 | Status: RECRUITING